1. Home
  2. BCAX
  3. BCAX Forecast

BCAX

BICARA THERAPEUTICS INC

as 12-18-2024 3:31pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

NYSE

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

More About Our BCAX ML Model...

What kind of parameters do you use to train BCAX stocks ML model?

To train our stocks BCAX ML model, we use historical data with over 25 parameters, including volume indicators, volatility indicators, momentum indicators, trend indicators, and other metrics.

How often do you update BCAX ML model?

We update our ML model either weekly or biweekly, depending on the market capitalization of the stocks, using TensorFlow, typically over the weekend.

Why is the accuracy of your BCAX model low?

Unfortunately, our current data provider offers limited historical data, which impacts the accuracy of our ML model. However, as we continue to gather more data over time and add more indicators, we expect the accuracy of our model to improve.

How can I provide and share more data with you to increase your ML model accuracy?

We would greatly appreciate your contribution. Please send an email to [email protected]

Do you offer an ML model for shorter time periods, such as 5 minutes or 15 minutes?

Yes, we offer it for strategy purposes only, with intervals: 1 minute, 2 minutes, 5 minutes, 15 minutes, and 30 minutes etc.

Can I rely on your ML model to make financial decisions regarding buying or selling stocks, or is it only intended for learning purposes?

Our ML model is primarily designed for educational purposes and is not intended to provide financial advice. We strongly recommend consulting with a financial advisor before making any buying or selling decisions.

Share on Social Networks: